12 results match your criteria: "University Hospital Centre of Tours[Affiliation]"

Cobalt-chromium toxicity following revision of total hip replacement.

Saudi Med J

February 2024

From the Department of Orthopedic Surgery and Traumatology (Samargandi, Le Nail, Saad), The Regional University Hospital Centre of Tours, Tours, France, and from the Department of Orthopedic Surgery (Samargandi, Hetaimish), College of Medicine, University of Jeddah, Jeddah, Kingdom of Saudi Arabia.

Systemic cobalt-chromium (Co-Cr) toxicity following a total hip replacement is a rare complication that may sometimes lead to fatal consequences. We report a case of a 64-year-old woman, who presented with Co-Cr toxicity after revision of fractured ceramic components with metal-on-polyethylene. Systemic toxicity occurred a year after surgery and was expressed brutally with mostly central neurological symptoms.

View Article and Find Full Text PDF

(1) Background: While inequalities in the prevalence of cancer, access to care, and survival have been well documented, less research has focused on inequalities in the uptake of supportive oncology care. Given its contribution to improving the quality of life of people affected by cancer, access to such care is a major public health issue. The present study focuses on the access and uptake of those supportive oncology care services.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the short-term outcomes of laparoscopic liver resection (LLR) in patients with and without cirrhosis across 27 medical centers from 2000 to 2017.
  • Out of 3,150 patients, those with cirrhosis experienced higher rates of severe complications, prolonged hospital stays, and increased risk of mortality compared to those without cirrhosis.
  • Despite being treated in expert centers, cirrhosis was still identified as an independent risk factor for negative outcomes, highlighting the challenges in managing such patients during LLR.
View Article and Find Full Text PDF

Operative versus conservative treatment for giant omphalocele: Study of French and Ivorian management.

Ann Chir Plast Esthet

April 2020

Visceral Pediatric Surgery Unit, University Hospital Centre of Tours, Gatien de Clocheville Hospital, 37000 Tours, France.

Introduction: The giant omphalocele is currently a surgical challenge. The morbidity and mortality associated with its care is non-negligible. Nowadays, different studies have revived the debate between conservative and surgical management for giant omphalocele.

View Article and Find Full Text PDF

Serum IgG Concentrations in Adult Patients Experiencing Virus-Induced Severe Asthma Exacerbations.

J Allergy Clin Immunol Pract

August 2020

Department of Respiratory Medicine, University Hospital Centre of Toulouse, Toulouse, France; Center for Pathophysiology Toulouse Purpan, INSERM U1043, CNRS UMR 5282, Toulouse III University, Toulouse, France. Electronic address:

Background: Patients experiencing severe asthma exacerbations have a poorer quality of life and an increase in morbidity and mortality. Viruses are frequently involved in asthma exacerbations.

Objective: To determine the value of measuring serum IgG concentrations in asthma exacerbations and assess their link with viral infections in patients hospitalized for asthma.

View Article and Find Full Text PDF

Purpose: The distinction between physiologic (innocent) and pathologic (organic) heart murmurs is not always easy in routine practice, leading too often to unnecessary cardiology referrals and expensive investigations. We aimed to test the hypothesis that the complete disappearance of murmur on standing can exclude cardiac disease in children.

Methods: From January 2014 to January 2015, we prospectively included 194 consecutive children aged 2 to 18 years who were referred for heart murmur evaluation to pediatric cardiologists at 2 French medical centers.

View Article and Find Full Text PDF

Objective: To assess quality of life and satisfaction regarding immunoglobulin-replacement therapy (IgRT) treatment according to the route (intravenous Ig [IVIg] or subcutaneous Ig [SCIg]) and place of administration (home-based IgRT or hospital-based IgRT).

Subjects And Methods: Children 5-15 years old treated for primary immunodeficiency disease (PIDD) with IgRT for ≥3 months were included in a prospective, noninterventional cohort study and followed over 12 months. Quality of life was assessed with the Child Health Questionnaire - parent form (CHQ-PF)-50 questionnaire.

View Article and Find Full Text PDF

Background: IgG replacement therapy (IgRT) in primary immunodeficiencies (PID) is a lifelong treatment which may be administered intravenously (IVIg) or subcutaneously (SCIg), at hospital or at home. The objective of the VISAGE study was to investigate if route and/or place for IgRT impact patients' satisfaction regarding IgRT and quality of life (QoL) in real-life conditions.

Methods: The study enrolled PID patients at least 15 years old receiving IgRT for at least 3 months.

View Article and Find Full Text PDF

Colorectal cancer (CRC) is an important public health issue in France, justifying a screening policy adapted to individual risk. The general practitioner (GP) is most commonly the initiator of CRC screening. The EDIFICE 2 survey, carried out in 2008 among 600 GPs, showed that 83% of GPs were convinced of the importance of screening, but that only 30% of GPs systematically recommended the procedure.

View Article and Find Full Text PDF

The EDIFICE survey was performed to ascertain how both the targeted general population and GPs in France deal with cancer screening and especially with screening programmes. The assessment of compliance to national official statements and professional guidelines, rates and trends of compliance, specific profiles of individuals who do and those who do not attend were investigated and are presented in this supplement.

View Article and Find Full Text PDF